(Q36641474)

15 August 2017

1 reference

title

Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease (English)

1 reference

15 August 2017

1 reference

1 reference

Dag Nyholm

1

1 reference

15 August 2017

publication date

1 October 2006

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

15 August 2017

published in

1 reference

15 August 2017

volume

6

1 reference

15 August 2017

issue

10

1 reference

15 August 2017

page(s)

1403-1411

1 reference

Prevalence and incidence of Parkinson's disease in Europe

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Impact of gastric emptying on levodopa pharmacokinetics in Parkinson disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Levodopa pharmacokinetics and motor performance during activities of daily living in patients with Parkinson's disease on individual drug combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Striatal plasticity and extrapyramidal motor dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Pathophysiology of motor fluctuations in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Levodopa infusion therapy in Parkinson disease: state of the art in 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Pharmacokinetic optimisation in the treatment of Parkinson's disease : an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Dopamine agonists in the treatment of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Levodopa in the treatment of Parkinson's disease: current controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Does levodopa slow or hasten the rate of progression of Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Drugs for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Pharmacokinetic-pharmacodynamic relationship of levodopa with and without tolcapone in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Other formulations and future considerations for apomorphine for subcutaneous injection therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Safety, tolerability, and efficacy of continuous transdermal dopaminergic stimulation with rotigotine patch in early-stage idiopathic Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Wireless real-time electronic data capture for self-assessment of motor function and quality of life in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Pharmacodynamic aspects of drug administration. Tolerance development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tablets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Duodenal levodopa infusion in Parkinson's disease--long-term experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

The 15D instrument of health-related quality of life: properties and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Complications and adverse effects of deep brain stimulation in Parkinson's patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

Motor fluctuations in levodopa treatment: clinical pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.10.1403

10.1586/14737175.6.10.1403

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference